Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

NCT01224288

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

NCT03291028

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +25 more
Locations: Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations: LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States

Montefiore Medical Center The Bronx, New York, United States

University of North Carolina Chapel Hill, North Carolina, United States

UC Health Cincinnati, Ohio, United States

View Trial Details

Active, not recruiting

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

NCT06855212

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, not recruiting

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

NCT04759911

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

University of Michigan Health Systems Ann Arbor, Michigan, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

NCT05546879

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de GRENOBLE ALPES Grenoble, Alpes, France

CHU Angers Angers, France

Hôpital Haut Lêveque Bordeaux, France

12 Hôpital St Joseph Marseille, France

View Trial Details

Active, not recruiting

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

NCT04388852

Conditions: Adenocarcinoma, Aggressive Variant Prostate Carcinoma, Carcinoma, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

3D Specimen Maps for RT Planning

NCT05743569

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +8 more
Locations: Vanderbilt Medical Center Nashville, Tennessee, United States

View Trial Details

Active, not recruiting

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NCT02984566

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Nepean Hospital Penrith, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Active, not recruiting

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

NCT06035224

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Shanghai Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions